Zobrazeno 1 - 10
of 104
pro vyhledávání: '"Yuichi J Shimada"'
Autor:
Satoshi Miyashita, Keitaro Akita, Yanling Zhao, Kohei Hasegawa, Mathew S. Maurer, Shepard D. Weiner, Muredach P. Reilly, Hiroo Takayama, Yuichi J. Shimada
Publikováno v:
ESC Heart Failure, Vol 10, Iss 4, Pp 2438-2446 (2023)
Abstract Aims Prior studies have suggested causal relationships between obesity and acute cardiovascular events. It has been also known that the risk of acute cardiovascular events is reduced by bariatric surgery. However, little is known about wheth
Externí odkaz:
https://doaj.org/article/53975e698d7040a696373c8dc5729cbe
Autor:
Tsuyoshi Yamabe, MD, Jonathan Ginns, MD, Vijay Vedula, PhD, Jay S. Leb, MD, Yuichi J. Shimada, MD, MPH, Shepard D. Weiner, MD, Hiroo Takayama, MD, PhD
Publikováno v:
JTCVS Open, Vol 11, Iss , Pp 105-115 (2022)
Objectives: The purpose of this study is to determine whether or not left ventricular remodeling can be induced after septal myectomy in patients with obstructive hypertrophic cardiomyopathy, and if so, how it occurs, using gated cardiac computed tom
Externí odkaz:
https://doaj.org/article/78d00edce5b949768d47063b35fe9206
Autor:
Lorenzo R. Sewanan, Yuichi J. Shimada
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 9 (2022)
Hypertrophic cardiomyopathy (HCM) is a complex but relatively common genetic disease that usually arises from pathogenic variants that disrupt sarcomere function and lead to variable structural, hypertrophic, and fibrotic remodeling of the heart whic
Externí odkaz:
https://doaj.org/article/68c1294299154bf797934c1326ed961e
Autor:
Bradley S. Lander, Yanling Zhao, Kohei Hasegawa, Mathew S. Maurer, Albree Tower-Rader, Michael A. Fifer, Muredach P. Reilly, Yuichi J. Shimada
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 9 (2022)
IntroductionIn hypertrophic cardiomyopathy (HCM), late gadolinium enhancement (LGE) on cardiac magnetic resonance imaging (CMR) represents myocardial fibrosis and is associated with sudden cardiac death. However, CMR requires particular expertise and
Externí odkaz:
https://doaj.org/article/1d4b77c3a8b64e2fb5174549fc803275
Autor:
Lusha W. Liang, Isha Kalia, Farhana Latif, Marc P. Waase, Yuichi J. Shimada, Gabriel Sayer, Muredach P. Reilly, Nir Uriel
Publikováno v:
Molecular Genetics & Genomic Medicine, Vol 10, Iss 6, Pp n/a-n/a (2022)
Abstract Background The COVID‐19 pandemic has necessitated the rapid and widespread adoption of novel mechanisms of service delivery, including the use of telemedicine. The aim of this study was to examine the impact of COVID‐19 on cardiogenetics
Externí odkaz:
https://doaj.org/article/2ee51d0369a74db68b073daed6a0eed6
Autor:
Sae X. Morita, Kenya Kusunose, Akihiro Haga, Masataka Sata, Kohei Hasegawa, Yoshihiko Raita, Muredach P. Reilly, Michael A. Fifer, Mathew S. Maurer, Yuichi J. Shimada
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 8 (2021)
Genetic testing provides valuable insights into family screening strategies, diagnosis, and prognosis in patients with hypertrophic cardiomyopathy (HCM). On the other hand, genetic testing carries socio-economical and psychological burdens. It is the
Externí odkaz:
https://doaj.org/article/1f400c5201b94c7dacbe01cbf415aa73
Autor:
Isao, Anzai, Hideyuki, Hayashi, Stephanie, Nguyen, Vijay, Vedula, Jay S, Leb, Yuichi J, Shimada, Shepard D, Weiner, Hiroo, Takayama
Publikováno v:
Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery. 18:11-15
Autor:
Lusha W. Liang, Yuichi J. Shimada
Publikováno v:
Circ Heart Fail
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 6 (2019)
Patients with obesity often have multiple cardiovascular comorbidities as obesity is an established risk factor for various cardiovascular diseases (CVDs)—e. g., heart failure (HF), coronary artery disease (CAD), hypertension, dysrhythmia, and veno
Externí odkaz:
https://doaj.org/article/9e2dcbe376ec4d87bd5443e7989acc5f
Autor:
Yujiro Yokoyama, Tomonari Shimoda, Yuichi J Shimada, Junichi Shimamura, Keitaro Akita, Risako Yasuda, Hiroo Takayama, Toshiki Kuno
Publikováno v:
European Journal of Cardio-Thoracic Surgery. 63
OBJECTIVESTo elucidate the optimal septal reduction therapy for obstructive hypertrophic cardiomyopathy, we conducted a meta-analysis comparing alcohol septal ablation (ASA) and septal myectomy.METHODSMEDLINE, EMBASE and Cochrane CENTRAL were searche